| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
China Pharma Holdings, Inc. (CPHI) specializes in the development, manufacturing, and marketing of both generic and branded pharmaceutical as well as biochemical products. The company primarily caters to hospitals and independent retailers throughout mainland China. Its comprehensive product portfolio encompasses diverse formulations, including powdered and liquid injectables, oral tablets, capsules, and cephalosporin-based oral solutions. CPHI's extensive range of medical solutions targets various health conditions. For neurological and …
Over the last 12 months, insiders at China Pharma Holdings, Inc. have bought $0 and sold $0 worth of China Pharma Holdings, Inc. stock.
On average, over the past 5 years, insiders at China Pharma Holdings, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2005-10-04 | Sale | HALTER TIMOTHY P | CEO, Pres, CFO, Chairman & Sec | 1.83M 4.7382% | $0.10 | $182,817 | -34.98% |
| Increased Positions | 3 | +42.86% | 18,163 | +30.13% |
| Decreased Positions | 3 | -42.86% | 49,144 | -81.53% |
| New Positions | 2 | New | 17,463 | New |
| Sold Out Positions | 2 | Sold Out | 30,466 | Sold Out |
| Total Postitions | 7 | 0% | 29,295 | -51.4% |
| Citadel Advisors Llc | $37.00 | 0.61% | 30,426 | +7,356 | +31.89% | 2025-09-30 |
| Ubs Group Ag | $23.00 | 0.38% | 19,191 | -52,042 | -73.06% | 2025-09-30 |
| Renaissance Technologies Llc | $13.00 | 0.21% | 10,618 | +10,618 | New | 2025-09-30 |
| Jpmorgan Chase & Co | $0 | <0.01% | 40 | +40 | New | 2025-09-30 |
| Danske Bank A/S | $0 | 0% | 1 | 0 | 0% | 2025-09-30 |
| Hrt Financial Lp | $0 | 0% | 0 | -16,168 | Sold Out | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $0 | 0% | 0 | -8,213 | Sold Out | 2025-09-30 |